TGTX EBITDA | TG THERAPEUTICS, INC.

TG THERAPEUTICS, INC. (TGTX) EBITDA

2026-06-30: Basis Reported; EBITDA $21.73M*; Operating income $21.67M; Depreciation and amortization $53.00K*.
2026-03-31: Basis Reported; EBITDA $34.83M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $50.52M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $29.38M*; Operating income $29.36M; Depreciation and amortization $17.00K*.

Complete source-backed ebitda history.

Available history: 2021-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$21.73M*	$21.67M	$53.00K*	$240.34M	9.04%*	$293.00K*	$39.26M*	$41.19M	$95.34M	$82.13M	$2.45M
2026-03-31	Reported	$34.83M	(m)	(m)	(m)	17.00%	$51.00K	-$17.89M	$33.51M	$48.40M	$88.22M	$586.00K
2025-12-31	Reported	$50.52M	(m)	(m)	(m)	26.23%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$29.38M*	$29.36M	$17.00K*	$161.71M	18.17%*	$80.00K*	-$23.15M*	$28.09M	$40.88M	$63.37M	-$364.99M
2025-06-30	Reported	$34.86M*	$34.84M	$13.00K*	$141.15M	24.69%*	$42.00K*	$7.44M*	$18.94M	$31.78M	$55.59M	$2.73M
2025-03-31	Reported	$8.63M	(m)	(m)	(m)	7.14%	$25.00K	-$28.71M	$15.54M	$46.36M	$50.33M	$408.00K
2024-12-31	Reported	$29.96M	(m)	(m)	(m)	27.69%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$12.45M*	$12.43M	$11.00K*	$83.88M	14.84%*	$24.00K*	-$12.21M*	$9.34M	$20.14M	$41.97M	$388.00K
2024-06-30	Reported	$8.84M*	$8.82M	$19.00K*	$73.47M	12.03%*	$0.00*	$5.54M*	$8.30M	$17.56M	$38.79M	-$328.00K
2024-03-31	Reported	-$9.24M	(m)	(m)	(m)	-14.56%	$0.00	-$8.21M	$5.44M	$32.72M	$34.58M	$29.00K
2023-12-31	Reported	-$12.45M	(m)	(m)	(m)	-28.31%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	$114.86M*	$114.78M	$73.00K*	$165.81M	69.27%*	(m)	$83.70M*	$3.51M	$14.75M	$32.77M	$0.00
2023-06-30	Reported	-$44.64M*	-$44.67M	$32.00K*	$16.07M	-277.73%*	(m)	-$42.01M*	$1.91M	$28.12M	$30.71M	$0.00
2023-03-31	Reported	-$36.92M	(m)	(m)	(m)	-473.20%	(m)	-$59.90M	$857.00K	$15.87M	$28.07M	(m)
2022-09-30	Reported	(m)	-$34.96M	(m)	$94.00K	(m)	$4.00K*	-$34.49M*	$2.00K	$20.80M	$14.25M	(m)
2022-06-30	Reported	(m)	-$38.94M	(m)	$594.00K	(m)	$0.00*	-$49.12M*	(m)	$26.87M	$12.64M	(m)
2022-03-31	Reported	(m)	-$66.87M	(m)	$2.02M	(m)	$7.00K	-$68.69M	(m)	$48.04M	$20.61M	(m)
2021-09-30	Reported	(m)	-$85.13M	(m)	(m)	(m)	$79.00K*	-$67.20M*	(m)	$51.97M	$34.90M	(m)
2021-06-30	Reported	(m)	-$77.49M	(m)	(m)	(m)	$175.00K*	-$60.17M*	(m)	$44.87M	$34.02M	(m)
2021-03-31	Reported	(m)	-$89.20M	(m)	(m)	(m)	$67.00K	-$81.36M	(m)	$63.09M	$26.76M	(m)
2020-09-30	Reported	(m)	-$85.72M	(m)	(m)	(m)	$89.00K*	-$56.53M*	(m)	$50.46M	$35.30M	(m)
2020-06-30	Reported	(m)	-$50.84M	(m)	(m)	(m)	$45.00K*	-$43.83M*	(m)	$36.45M	$14.43M	(m)
2020-03-31	Reported	(m)	-$50.24M	(m)	(m)	(m)	$68.00K	-$62.12M	(m)	$36.02M	$14.26M	(m)
2019-09-30	Reported	(m)	-$60.86M	(m)	(m)	(m)	$65.00K*	-$33.20M*	(m)	$57.98M	(m)	(m)
2019-06-30	Reported	(m)	-$35.54M	(m)	(m)	(m)	$18.00K*	-$35.86M*	(m)	$32.87M	(m)	(m)
2019-03-31	Reported	(m)	-$34.69M	(m)	(m)	(m)	$14.00K	-$33.35M	(m)	$32.38M	(m)	(m)
2018-09-30	Reported	(m)	-$34.33M	(m)	(m)	(m)	$26.00K*	(m)	(m)	$33.40M	(m)	(m)
2018-06-30	Reported	(m)	$44.34M	(m)	(m)	(m)	$34.00K*	(m)	(m)	$38.70M	(m)	(m)
2018-03-31	Reported	(m)	-$41.58M	(m)	(m)	(m)	$24.00K	(m)	(m)	$35.02M	(m)	(m)
2017-09-30	Reported	(m)	-$31.59M	(m)	(m)	(m)	$0.00*	(m)	(m)	$27.15M	(m)	(m)
2017-06-30	Reported	(m)	-$28.43M	(m)	(m)	(m)	$2.00K*	(m)	(m)	$26.71M	(m)	(m)
2017-03-31	Reported	(m)	-$27.67M	(m)	(m)	(m)	$0.00	(m)	(m)	$22.68M	(m)	(m)
2016-09-30	Reported	(m)	-$24.93M	(m)	(m)	(m)	$12.96K*	(m)	(m)	$21.80M	(m)	(m)
2016-06-30	Reported	(m)	-$16.02M	(m)	(m)	(m)	$27.80K*	(m)	(m)	$13.53M	(m)	(m)
2016-03-31	Reported	(m)	-$13.99M	(m)	(m)	(m)	$282.26K	(m)	(m)	$11.62M	(m)	(m)
2015-09-30	Reported	(m)	-$13.83M	(m)	(m)	(m)	$38.91K*	(m)	(m)	$11.57M	(m)	(m)
2015-06-30	Reported	(m)	-$17.11M	(m)	(m)	(m)	$13.40K*	(m)	(m)	$11.26M	(m)	(m)
2015-03-31	Reported	(m)	-$14.60M	(m)	(m)	(m)	$6.88K	(m)	(m)	$9.62M	(m)	(m)
2014-09-30	Reported	(m)	-$17.44M	(m)	(m)	(m)	$1.33K*	(m)	(m)	$13.69M	(m)	(m)
2014-06-30	Reported	(m)	-$11.96M	(m)	(m)	(m)	$0.00*	(m)	(m)	$6.85M	(m)	(m)
2014-03-31	Reported	(m)	-$7.61M	(m)	(m)	(m)	$3.17K	(m)	(m)	$4.41M	(m)	$0.00
2013-09-30	Reported	(m)	-$4.65M	(m)	(m)	(m)	$1.63K*	-$1.15M*	(m)	$3.31M	(m)	$0.00
2013-06-30	Reported	(m)	-$6.63M	(m)	(m)	(m)	$1.67K*	-$2.56M*	(m)	$5.03M	(m)	$0.00
2013-03-31	Reported	(m)	-$3.71M	(m)	(m)	(m)	$0.00	-$2.20M	(m)	$1.57M	(m)	$0.00
2012-09-30	Reported	(m)	-$2.71M	(m)	(m)	(m)	$0.00*	-$2.99M*	(m)	$1.56M	(m)	$0.00
2012-06-30	Reported	(m)	-$3.10M	(m)	(m)	(m)	$1.40K*	-$499.79K*	(m)	$1.65M	(m)	$0.00
2012-03-31	Reported	(m)	-$17.39M	(m)	(m)	(m)	$0.00	-$861.63K	(m)	$16.74M	(m)	$0.00
2011-09-30	Reported	(m)	-$30.11K	(m)	(m)	(m)	$0.00*	-$30.11K*	(m)	$15.94K	(m)	(m)
2011-06-30	Reported	(m)	-$297.00K	(m)	(m)	(m)	(m)	(m)	(m)	$297.00K	(m)	(m)
2010-09-30	Reported	(m)	-$515.63K	(m)	(m)	(m)	$0.00*	-$412.73K*	(m)	$236.73K	(m)	(m)
2010-06-30	Reported	(m)	-$525.09K	(m)	(m)	(m)	(m)	(m)	(m)	$51.00K	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$123.38M	(m)	(m)	(m)	20.02%	$214.00K	-$24.77M	$100.71M	$160.22M	$232.03M	-$339.79M
2024-12-31	Reported	$42M	(m)	(m)	(m)	12.76%	$45.00K	-$40.52M	$38.49M	$94.29M	$154.30M	$2.21M
2023-12-31	Reported	$20.84M	(m)	(m)	(m)	8.92%	$0.00	-$31.41M	$14.13M	$76.19M	$122.71M	$390.00K
2022-12-31	Reported	-$218.01M	(m)	(m)	(m)	-7828.11%	$14.00K	-$176.17M	$265.00K	$125.35M	$95.48M	$0.00
2021-12-31	Reported	-$344.49M	(m)	(m)	(m)	-5150.07%	$401.00K	-$295.63M	$790.00K	$222.58M	$128.09M	$0.00
2020-12-31	Reported	(m)	-$273.59M	(m)	(m)	(m)	$357.00K	-$214.51M	(m)	$165.90M	$107.85M	$0.00
2019-12-31	Reported	(m)	-$169.06M	(m)	(m)	(m)	$131.00K	-$132.81M	(m)	$154.18M	$15.03M	$0.00
2018-12-31	Reported	(m)	-$174.40M	(m)	(m)	(m)	$90.00K	-$128.93M	(m)	$159.39M	(m)	$0.00
2017-12-31	Reported	(m)	-$118.71M	(m)	(m)	(m)	$2.00K	-$93.76M	(m)	$102.53M	(m)	$0.00
2016-12-31	Reported	(m)	-$78.97M	(m)	(m)	(m)	$344.00K	(m)	(m)	$69.23M	(m)	$0.00
2015-12-31	Reported	(m)	-$63.18M	(m)	(m)	(m)	$42.22K	(m)	(m)	$47.71M	(m)	$0.00
2014-12-31	Reported	(m)	-$55.72M	(m)	(m)	(m)	$18.57K	(m)	(m)	$40.09M	(m)	$0.00
2013-12-31	Reported	(m)	-$22.97M	(m)	(m)	(m)	$5.68K	(m)	(m)	$13.66M	(m)	$0.00
2012-12-31	Reported	(m)	-$26.90M	(m)	(m)	(m)	$1.40K	-$5.19M	(m)	$21.03M	(m)	$300.00K
2012-03-31	Reported	(m)	-$18.27M	(m)	(m)	(m)	(m)	-$948.21K	(m)	$17.07M	(m)	(m)
2011-12-31	Reported	(m)	-$881.97K	(m)	(m)	(m)	$0.00	-$86.58K	(m)	$327.28K	(m)	$0.00

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Protagonist Therapeutics, Inc (PTGX)	United States	$8.883B	95.52
CYTOKINETICS INC (CYTK)	United States	$9.130B	-11.86
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)	United States	$9.331B	-42.28
Praxis Precision Medicines, Inc. (PRAX)	United States	$7.884B	-27.60
Structure Therapeutics Inc. (GPCR)	United States	$7.710B	-53.41
Spyre Therapeutics, Inc. (SYRE)	United States	$7.685B	-43.69
Axsome Therapeutics, Inc. (AXSM)	United States	$10.274B	-66.82
IONIS PHARMACEUTICALS INC (IONS)	United States	$7.277B	-23.25
Alkermes plc. (ALKS)		$6.844B	132.74
RHYTHM PHARMACEUTICALS, INC. (RYTM)	United States	$6.771B	-37.20